Cargando…

High-throughput gadobutrol-enhanced CMR: a time and dose optimization study

BACKGROUND: Reducing time and contrast agent doses are important goals to provide cost-efficient cardiovascular magnetic resonance (CMR) imaging. Limited information is available regarding the feasibility of evaluating left ventricular (LV) function after gadobutrol injection as well as defining the...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Angelo, Tommaso, Grigoratos, Chrysanthos, Mazziotti, Silvio, Bratis, Konstantinos, Pathan, Faraz, Blandino, Alfredo, Elen, Elen, Puntmann, Valentina O., Nagel, Eike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674223/
https://www.ncbi.nlm.nih.gov/pubmed/29110679
http://dx.doi.org/10.1186/s12968-017-0400-4
_version_ 1783276731427192832
author D’Angelo, Tommaso
Grigoratos, Chrysanthos
Mazziotti, Silvio
Bratis, Konstantinos
Pathan, Faraz
Blandino, Alfredo
Elen, Elen
Puntmann, Valentina O.
Nagel, Eike
author_facet D’Angelo, Tommaso
Grigoratos, Chrysanthos
Mazziotti, Silvio
Bratis, Konstantinos
Pathan, Faraz
Blandino, Alfredo
Elen, Elen
Puntmann, Valentina O.
Nagel, Eike
author_sort D’Angelo, Tommaso
collection PubMed
description BACKGROUND: Reducing time and contrast agent doses are important goals to provide cost-efficient cardiovascular magnetic resonance (CMR) imaging. Limited information is available regarding the feasibility of evaluating left ventricular (LV) function after gadobutrol injection as well as defining the lowest dose for high quality scar imaging. We sought to evaluate both aspects separately and systematically to provide an optimized protocol for contrast-enhanced CMR (CE-CMR) using gadobutrol. METHODS: This is a prospective, randomized, single-blind cross-over study performed in two different populations. The first population consisted of 30 patients with general indications for a rest CE-CMR who underwent cine-imaging before and immediately after intravenous administration of 0.1 mmol/kg body-weight of gadobutrol. Quantitative assessment of LV volumes and function was performed by the same reader in a randomized and blinded fashion. The second population was composed of 30 patients with indication to late gadolinium enhancement (LGE) imaging, which was performed twice at different gadobutrol doses (0.1 mmol/kg vs. 0.2 mmol/kg) and at different time delays (5 and 10 min vs. 5, 10, 15 and 20 min), within a maximal interval of 21 days. LGE images were analysed qualitatively (contrast-to-noise ratio) and quantitatively (LGE%-of-mass). RESULTS: Excellent correlation between pre- and post-contrast cine-imaging was found, with no difference of LV stroke volume and ejection fraction (p = 0.538 and p = 0.095, respectively). End-diastolic-volume and end-systolic-volume were measured significantly larger after contrast injection (p = 0.008 and p = 0.001, respectively), with a mean difference of 3.7 ml and 2.9 ml, respectively. LGE imaging resulted in optimal contrast-to-noise ratios 10 min post-injection for a gadobutrol dose of 0.1 mmol/kg body-weight and 20 min for a dose of 0.2 mmol/kg body-weight. At these time points LGE quantification did not significantly differ (0.1 mmol/kg: 11% (16.4); 0.2 mmol/kg: 12% (14.5); p = 0.059), showing excellent correlation (ICC = 0.957; p < 0.001). CONCLUSION: A standardized CE-CMR rest protocol giving a dose of 0.1 mmol/kg of gadobutrol before cine-imaging and performing LGE 10 min after injection represents a fast low-dose protocol without significant loss of information in comparison to a longer protocol with cine-imaging before contrast injection and a higher dose of gadobutrol. This approach allows to reduce examination time and costs as well as minimize contrast-agent exposure. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12968-017-0400-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5674223
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56742232017-11-15 High-throughput gadobutrol-enhanced CMR: a time and dose optimization study D’Angelo, Tommaso Grigoratos, Chrysanthos Mazziotti, Silvio Bratis, Konstantinos Pathan, Faraz Blandino, Alfredo Elen, Elen Puntmann, Valentina O. Nagel, Eike J Cardiovasc Magn Reson Research BACKGROUND: Reducing time and contrast agent doses are important goals to provide cost-efficient cardiovascular magnetic resonance (CMR) imaging. Limited information is available regarding the feasibility of evaluating left ventricular (LV) function after gadobutrol injection as well as defining the lowest dose for high quality scar imaging. We sought to evaluate both aspects separately and systematically to provide an optimized protocol for contrast-enhanced CMR (CE-CMR) using gadobutrol. METHODS: This is a prospective, randomized, single-blind cross-over study performed in two different populations. The first population consisted of 30 patients with general indications for a rest CE-CMR who underwent cine-imaging before and immediately after intravenous administration of 0.1 mmol/kg body-weight of gadobutrol. Quantitative assessment of LV volumes and function was performed by the same reader in a randomized and blinded fashion. The second population was composed of 30 patients with indication to late gadolinium enhancement (LGE) imaging, which was performed twice at different gadobutrol doses (0.1 mmol/kg vs. 0.2 mmol/kg) and at different time delays (5 and 10 min vs. 5, 10, 15 and 20 min), within a maximal interval of 21 days. LGE images were analysed qualitatively (contrast-to-noise ratio) and quantitatively (LGE%-of-mass). RESULTS: Excellent correlation between pre- and post-contrast cine-imaging was found, with no difference of LV stroke volume and ejection fraction (p = 0.538 and p = 0.095, respectively). End-diastolic-volume and end-systolic-volume were measured significantly larger after contrast injection (p = 0.008 and p = 0.001, respectively), with a mean difference of 3.7 ml and 2.9 ml, respectively. LGE imaging resulted in optimal contrast-to-noise ratios 10 min post-injection for a gadobutrol dose of 0.1 mmol/kg body-weight and 20 min for a dose of 0.2 mmol/kg body-weight. At these time points LGE quantification did not significantly differ (0.1 mmol/kg: 11% (16.4); 0.2 mmol/kg: 12% (14.5); p = 0.059), showing excellent correlation (ICC = 0.957; p < 0.001). CONCLUSION: A standardized CE-CMR rest protocol giving a dose of 0.1 mmol/kg of gadobutrol before cine-imaging and performing LGE 10 min after injection represents a fast low-dose protocol without significant loss of information in comparison to a longer protocol with cine-imaging before contrast injection and a higher dose of gadobutrol. This approach allows to reduce examination time and costs as well as minimize contrast-agent exposure. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12968-017-0400-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-06 /pmc/articles/PMC5674223/ /pubmed/29110679 http://dx.doi.org/10.1186/s12968-017-0400-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
D’Angelo, Tommaso
Grigoratos, Chrysanthos
Mazziotti, Silvio
Bratis, Konstantinos
Pathan, Faraz
Blandino, Alfredo
Elen, Elen
Puntmann, Valentina O.
Nagel, Eike
High-throughput gadobutrol-enhanced CMR: a time and dose optimization study
title High-throughput gadobutrol-enhanced CMR: a time and dose optimization study
title_full High-throughput gadobutrol-enhanced CMR: a time and dose optimization study
title_fullStr High-throughput gadobutrol-enhanced CMR: a time and dose optimization study
title_full_unstemmed High-throughput gadobutrol-enhanced CMR: a time and dose optimization study
title_short High-throughput gadobutrol-enhanced CMR: a time and dose optimization study
title_sort high-throughput gadobutrol-enhanced cmr: a time and dose optimization study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674223/
https://www.ncbi.nlm.nih.gov/pubmed/29110679
http://dx.doi.org/10.1186/s12968-017-0400-4
work_keys_str_mv AT dangelotommaso highthroughputgadobutrolenhancedcmratimeanddoseoptimizationstudy
AT grigoratoschrysanthos highthroughputgadobutrolenhancedcmratimeanddoseoptimizationstudy
AT mazziottisilvio highthroughputgadobutrolenhancedcmratimeanddoseoptimizationstudy
AT bratiskonstantinos highthroughputgadobutrolenhancedcmratimeanddoseoptimizationstudy
AT pathanfaraz highthroughputgadobutrolenhancedcmratimeanddoseoptimizationstudy
AT blandinoalfredo highthroughputgadobutrolenhancedcmratimeanddoseoptimizationstudy
AT elenelen highthroughputgadobutrolenhancedcmratimeanddoseoptimizationstudy
AT puntmannvalentinao highthroughputgadobutrolenhancedcmratimeanddoseoptimizationstudy
AT nageleike highthroughputgadobutrolenhancedcmratimeanddoseoptimizationstudy